Logo image of ELVA

ELECTROVAYA INC (ELVA) Stock Fundamental Analysis

NASDAQ:ELVA - Nasdaq - CA28617B6061 - Common Stock - Currency: USD

2.29  -0.1 (-4.18%)

Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to ELVA. ELVA was compared to 93 industry peers in the Electrical Equipment industry. ELVA has a bad profitability rating. Also its financial health evaluation is rather negative. ELVA is not valued too expensively and it also shows a decent growth rate.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

ELVA had negative earnings in the past year.
In the past year ELVA had a positive cash flow from operations.
In the past 5 years ELVA reported 4 times negative net income.
In the past 5 years ELVA reported 4 times negative operating cash flow.
ELVA Yearly Net Income VS EBIT VS OCF VS FCFELVA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -5M -10M -15M -20M

1.2 Ratios

ELVA has a Return On Assets of -3.76%. This is in the better half of the industry: ELVA outperforms 61.96% of its industry peers.
ELVA has a Return On Equity (-17.30%) which is in line with its industry peers.
The Return On Invested Capital of ELVA (5.29%) is better than 73.91% of its industry peers.
Industry RankSector Rank
ROA -3.76%
ROE -17.3%
ROIC 5.29%
ROA(3y)-14.68%
ROA(5y)-16.77%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ELVA Yearly ROA, ROE, ROICELVA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500 1K 1.5K

1.3 Margins

With a decent Operating Margin value of 4.41%, ELVA is doing good in the industry, outperforming 71.74% of the companies in the same industry.
ELVA has a Gross Margin of 30.68%. This is in the better half of the industry: ELVA outperforms 72.83% of its industry peers.
In the last couple of years the Gross Margin of ELVA has declined.
Industry RankSector Rank
OM 4.41%
PM (TTM) N/A
GM 30.68%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-3.22%
GM growth 5Y-5.01%
ELVA Yearly Profit, Operating, Gross MarginsELVA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -200 -400 -600 -800

1

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), ELVA is destroying value.
ELVA has more shares outstanding than it did 1 year ago.
ELVA has more shares outstanding than it did 5 years ago.
ELVA has a worse debt/assets ratio than last year.
ELVA Yearly Shares OutstandingELVA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M
ELVA Yearly Total Debt VS Total AssetsELVA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M

2.2 Solvency

ELVA has an Altman-Z score of -1.58. This is a bad value and indicates that ELVA is not financially healthy and even has some risk of bankruptcy.
ELVA has a worse Altman-Z score (-1.58) than 68.48% of its industry peers.
The Debt to FCF ratio of ELVA is 22.75, which is on the high side as it means it would take ELVA, 22.75 years of fcf income to pay off all of its debts.
Looking at the Debt to FCF ratio, with a value of 22.75, ELVA is in the better half of the industry, outperforming 65.22% of the companies in the same industry.
ELVA has a Debt/Equity ratio of 2.36. This is a high value indicating a heavy dependency on external financing.
ELVA's Debt to Equity ratio of 2.36 is on the low side compared to the rest of the industry. ELVA is outperformed by 79.35% of its industry peers.
Industry RankSector Rank
Debt/Equity 2.36
Debt/FCF 22.75
Altman-Z -1.58
ROIC/WACC0.66
WACC8.02%
ELVA Yearly LT Debt VS Equity VS FCFELVA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M -10M

2.3 Liquidity

ELVA has a Current Ratio of 1.03. This is a normal value and indicates that ELVA is financially healthy and should not expect problems in meeting its short term obligations.
The Current ratio of ELVA (1.03) is worse than 78.26% of its industry peers.
ELVA has a Quick Ratio of 1.03. This is a bad value and indicates that ELVA is not financially healthy enough and could expect problems in meeting its short term obligations.
ELVA has a worse Quick ratio (0.69) than 75.00% of its industry peers.
Industry RankSector Rank
Current Ratio 1.03
Quick Ratio 0.69
ELVA Yearly Current Assets VS Current LiabilitesELVA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M 25M

6

3. Growth

3.1 Past

The earnings per share for ELVA have decreased strongly by -300.00% in the last year.
The Revenue has been growing slightly by 1.26% in the past year.
The Revenue has been growing by 55.61% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)-300%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
Revenue 1Y (TTM)1.26%
Revenue growth 3Y56.77%
Revenue growth 5Y55.61%
Sales Q2Q%-7.62%

3.2 Future

The Earnings Per Share is expected to grow by 104.77% on average over the next years. This is a very strong growth
Based on estimates for the next years, ELVA will show a very strong growth in Revenue. The Revenue will grow by 39.75% on average per year.
EPS Next Y474%
EPS Next 2Y290.64%
EPS Next 3Y156.93%
EPS Next 5Y104.77%
Revenue Next Year50.75%
Revenue Next 2Y54.79%
Revenue Next 3Y52.49%
Revenue Next 5Y39.75%

3.3 Evolution

Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
ELVA Yearly Revenue VS EstimatesELVA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 100M 200M 300M 400M
ELVA Yearly EPS VS EstimatesELVA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 0 1 -1 2

6

4. Valuation

4.1 Price/Earnings Ratio

ELVA reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Based on the Price/Forward Earnings ratio of 5.76, the valuation of ELVA can be described as very cheap.
Based on the Price/Forward Earnings ratio, ELVA is valued cheaply inside the industry as 98.91% of the companies are valued more expensively.
When comparing the Price/Forward Earnings ratio of ELVA to the average of the S&P500 Index (22.70), we can say ELVA is valued rather cheaply.
Industry RankSector Rank
PE N/A
Fwd PE 5.76
ELVA Price Earnings VS Forward Price EarningsELVA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 -40

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of ELVA indicates a somewhat cheap valuation: ELVA is cheaper than 68.48% of the companies listed in the same industry.
67.39% of the companies in the same industry are more expensive than ELVA, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 85.61
EV/EBITDA 25.1
ELVA Per share dataELVA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.2 0.4 0.6 0.8 1

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as ELVA's earnings are expected to grow with 156.93% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y290.64%
EPS Next 3Y156.93%

0

5. Dividend

5.1 Amount

No dividends for ELVA!.
Industry RankSector Rank
Dividend Yield N/A

ELECTROVAYA INC

NASDAQ:ELVA (2/21/2025, 8:15:37 PM)

2.29

-0.1 (-4.18%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryElectrical Equipment
Earnings (Last)02-13 2025-02-13/amc
Earnings (Next)05-12 2025-05-12/amc
Inst Owners15.7%
Inst Owner ChangeN/A
Ins Owners39.66%
Ins Owner ChangeN/A
Market Cap78.16M
Analysts82
Price Target3.92 (71.18%)
Short Float %0.64%
Short Ratio1.16
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-9.8%
Min EPS beat(2)-119.61%
Max EPS beat(2)100%
EPS beat(4)2
Avg EPS beat(4)-23.28%
Min EPS beat(4)-173.52%
Max EPS beat(4)100%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-25.45%
Min Revenue beat(2)-45.33%
Max Revenue beat(2)-5.56%
Revenue beat(4)0
Avg Revenue beat(4)-22.46%
Min Revenue beat(4)-45.33%
Max Revenue beat(4)-2.89%
Revenue beat(8)1
Avg Revenue beat(8)-14.41%
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)1.2%
PT rev (3m)7.48%
EPS NQ rev (1m)25.02%
EPS NQ rev (3m)-117.86%
EPS NY rev (1m)-48.44%
EPS NY rev (3m)-43.59%
Revenue NQ rev (1m)-2.21%
Revenue NQ rev (3m)-37.49%
Revenue NY rev (1m)-3.06%
Revenue NY rev (3m)-16.41%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 5.76
P/S 1.75
P/FCF 85.61
P/OCF 75.3
P/B 9.1
P/tB 9.1
EV/EBITDA 25.1
EPS(TTM)-0.04
EYN/A
EPS(NY)0.4
Fwd EY17.37%
FCF(TTM)0.03
FCFY1.17%
OCF(TTM)0.03
OCFY1.33%
SpS1.31
BVpS0.25
TBVpS0.25
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -3.76%
ROE -17.3%
ROCE 17.96%
ROIC 5.29%
ROICexc 5.43%
ROICexgc 5.43%
OM 4.41%
PM (TTM) N/A
GM 30.68%
FCFM 2.05%
ROA(3y)-14.68%
ROA(5y)-16.77%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-3.22%
GM growth 5Y-5.01%
F-Score6
Asset Turnover1.13
Health
Industry RankSector Rank
Debt/Equity 2.36
Debt/FCF 22.75
Debt/EBITDA 6.39
Cap/Depr 10.34%
Cap/Sales 0.28%
Interest Coverage 0.88
Cash Conversion 32.68%
Profit Quality N/A
Current Ratio 1.03
Quick Ratio 0.69
Altman-Z -1.58
F-Score6
WACC8.02%
ROIC/WACC0.66
Cap/Depr(3y)26.17%
Cap/Depr(5y)54.51%
Cap/Sales(3y)0.56%
Cap/Sales(5y)1.36%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-300%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
EPS Next Y474%
EPS Next 2Y290.64%
EPS Next 3Y156.93%
EPS Next 5Y104.77%
Revenue 1Y (TTM)1.26%
Revenue growth 3Y56.77%
Revenue growth 5Y55.61%
Sales Q2Q%-7.62%
Revenue Next Year50.75%
Revenue Next 2Y54.79%
Revenue Next 3Y52.49%
Revenue Next 5Y39.75%
EBIT growth 1Y140.76%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year383.42%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y115.91%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y119.83%
OCF growth 3YN/A
OCF growth 5YN/A